At a glance
ClinicalIndex Comparison RecordN/ACompleted· 171 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Enhanced Recovery After Surgery Protocol (ERAS) in Colorectal Surgery Diminishes the Negative Impact of Sarcopenia on Short Term Outcomes
In Brief
An observational study for Sarcopenia and Colonic Neoplasms. Completed, enrolled 171 participants across 1 site.
Detailed Summary
So far, the impact of sarcopenia has been analysed only in patients undergoing traditional surgical procedures (laparotomy) or those with metastatic spread. As the ERAS protocol combined with minimally invasive access decreases postoperative metabolic disorders, it seems possible that it can limit the deleterious impact of sarcopenia as well. The aim of this study was to investigate whether the use of ERAS protocol in colorectal cancer patients influences the postoperative risk due to sarcopenia.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsSarcopenia, Colonic Neoplasms
CountriesPoland
Collaborators--
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartJan 2014
Primary CompletionOct 2015
Study CompletionNov 2015
First PostedDec 2015
TodayJul 2026
First PostedDec 1, 2015
Enrollment StartJan 1, 2014
Primary CompletionOct 1, 2015
Study CompletionNov 1, 2015
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 10.6 years ago